Coca-Cola Femsa SAB de CV ADR (KOF)vsNiagen Bioscience, Inc. (NAGE)
KOF
Coca-Cola Femsa SAB de CV ADR
$115.47
+0.20%
CONSUMER DEFENSIVE · Cap: $24.81B
NAGE
Niagen Bioscience, Inc.
$2.54
+1.60%
CONSUMER DEFENSIVE · Cap: $197.02M
Smart Verdict
WallStSmart Research — data-driven comparison
Coca-Cola Femsa SAB de CV ADR generates 229360% more annual revenue ($296.20B vs $129.08M). NAGE leads profitability with a 12.4% profit margin vs 8.1%. NAGE trades at a lower P/E of 13.1x. KOF earns a higher WallStSmart Score of 56/100 (C).
KOF
Buy56
out of 100
Grade: C
NAGE
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+59.6%
Fair Value
$279.04
Current Price
$115.47
$163.57 discount
Intrinsic value data unavailable for NAGE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Generating 8.9B in free cash flow
Conservative balance sheet, low leverage
Every $100 of equity generates 23 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
4.7% revenue growth
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Operating margin of 2.4%
Revenue declined 4.3%
Earnings declined 75.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : KOF
The strongest argument for KOF centers on Free Cash Flow.
Bull Case : NAGE
The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.
Bear Case : KOF
The primary concerns for KOF are Revenue Growth, Piotroski F-Score, PEG Ratio. A P/E of 149.5x leaves little room for execution misses.
Bear Case : NAGE
The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.
Key Dynamics to Monitor
KOF profiles as a value stock while NAGE is a declining play — different risk/reward profiles.
NAGE carries more volatility with a beta of 2.02 — expect wider price swings.
KOF is growing revenue faster at 4.7% — sustainability is the question.
KOF generates stronger free cash flow (8.9B), providing more financial flexibility.
Bottom Line
KOF scores higher overall (56/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Coca-Cola Femsa SAB de CV ADR
CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA
Coca-Cola FEMSA, SAB de CV, a franchise bottler, produces, markets, sells and distributes Coca-Cola brand beverages. The company is headquartered in Mexico City, Mexico.
Visit Website →Niagen Bioscience, Inc.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
Compare with Other BEVERAGES - NON-ALCOHOLIC Stocks
Want to dig deeper into these stocks?